LGM

Logos Global Management Portfolio holdings

AUM $749M
This Quarter Return
-11.95%
1 Year Return
+18.94%
3 Year Return
+431.72%
5 Year Return
+481.1%
10 Year Return
–
AUM
$545M
AUM Growth
+$545M
Cap. Flow
-$111M
Cap. Flow %
-20.36%
Top 10 Hldgs %
72.8%
Holding
51
New
4
Increased
7
Reduced
16
Closed
19

Top Buys

1
SRPT icon
Sarepta Therapeutics
SRPT
$30M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$27.9M
3
APLS icon
Apellis Pharmaceuticals
APLS
$27.1M
4
CCXI
ChemoCentryx, Inc.
CCXI
$14.9M
5
BCYC
Bicycle Therapeutics
BCYC
$12.6M

Top Sells

1
GBT
Global Blood Therapeutics, Inc.
GBT
$43.3M
2
ISEE
IVERIC bio, Inc. Common Stock
ISEE
$30.3M
3
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
$28.8M
4
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
$24M
5
ASND icon
Ascendis Pharma
ASND
$20.5M

Sector Composition

1 Healthcare 97.27%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
TYRA icon
26
Tyra Biosciences
TYRA
$675M
$1.19M 0.22%
166,526
-86,200
-34% -$617K
LIAN
27
DELISTED
LianBio American Depositary Shares
LIAN
$852K 0.16%
394,486
-18,351
-4% -$39.6K
ATHA icon
28
Athira Pharma
ATHA
$15.3M
$671K 0.12%
220,000
-497,285
-69% -$1.52M
VIGL
29
DELISTED
Vigil Neuroscience
VIGL
$530K 0.1%
205,595
– –
PYXS icon
30
Pyxis Oncology
PYXS
$79.4M
$525K 0.1%
220,434
-66,218
-23% -$158K
NUVL icon
31
Nuvalent
NUVL
$5.52B
$460K 0.08%
33,887
-100,763
-75% -$1.37M
NUVB.WS icon
32
Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
NUVB.WS
$68M
$19K ﹤0.01%
66,666
– –
ASND icon
33
Ascendis Pharma
ASND
$11.8B
– –
-175,000
Closed -$20.5M
BMEA icon
34
Biomea Fusion
BMEA
$116M
– –
-200,000
Closed -$892K
CGEM icon
35
Cullinan Oncology
CGEM
$445M
– –
-200,000
Closed -$2.09M
COGT icon
36
Cogent Biosciences
COGT
$1.69B
– –
-150,000
Closed -$1.12M
IMA
37
ImageneBio, Inc. Common Stock
IMA
$150M
– –
-178,281
Closed -$1.09M
IOVA icon
38
Iovance Biotherapeutics
IOVA
$807M
– –
-1,000,000
Closed -$16.7M
SRRK icon
39
Scholar Rock
SRRK
$3.14B
– –
-675,000
Closed -$8.7M
VERA icon
40
Vera Therapeutics
VERA
$1.38B
– –
-385,000
Closed -$9.04M
VERV
41
DELISTED
Verve Therapeutics
VERV
– –
-96,912
Closed -$2.21M
VRNA
42
Verona Pharma
VRNA
$9.16B
– –
-300,000
Closed -$1.5M
VTGN icon
43
VistaGen Therapeutics
VTGN
$102M
– –
-1,000,000
Closed -$1.24M
OMGA
44
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
– –
-12,986
Closed -$81K
RAIN
45
DELISTED
Rain Oncology Inc. Common Stock
RAIN
– –
-134,194
Closed -$680K
MRTX
46
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
– –
-350,000
Closed -$28.8M
SLGC
47
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
– –
-100,000
Closed -$802K
ISEE
48
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
– –
-1,800,000
Closed -$30.3M
JNCE
49
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
– –
-1,400,000
Closed -$9.51M
GBT
50
DELISTED
Global Blood Therapeutics, Inc.
GBT
– –
-1,250,000
Closed -$43.3M
1
2
3